AI vs. radiologists: 150,000 women in landmark breast cancer screening trial
NCT ID NCT06032390
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether artificial intelligence (AI) can help detect breast cancer in mammograms as well as the current standard of two radiologists reading each scan. About 150,000 women in Norway's breast screening program will take part. The goal is to see if AI-assisted reading finds at least as many cancers as the usual double-reading method.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Cancer Registry of Norway, Norwegian Institute of Public Health
RECRUITINGOslo, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••